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Abstract
The a-proteobacterium Wolbachia pipientis infects more than 65% of insect species worldwide and manipulates the host
reproductive machinery to enable its own survival. It can live in mutualistic relationships with hosts that cause human
disease, including mosquitoes that carry the Dengue virus. Like many other bacteria, Wolbachia contains disulfide bond
forming (Dsb) proteins that introduce disulfide bonds into secreted effector proteins. The genome of the Wolbachia strain
wMel encodes two DsbA-like proteins sharing just 21% sequence identity to each other, a-DsbA1 and a-DsbA2, and an
integral membrane protein, a-DsbB. a-DsbA1 and a-DsbA2 both have a Cys-X-X-Cys active site that, by analogy with
Escherichia coli DsbA, would need to be oxidized to the disulfide form to serve as a disulfide bond donor toward substrate
proteins. Here we show that the integral membrane protein a-DsbB oxidizes a-DsbA1, but not a-DsbA2. The interaction
between a-DsbA1 and a-DsbB is very specific, involving four essential cysteines located in the two periplasmic loops of a-
DsbB. In the electron flow cascade, oxidation of a-DsbA1 by a-DsbB is initiated by an oxidizing quinone cofactor that
interacts with the cysteine pair in the first periplasmic loop. Oxidizing power is transferred to the second cysteine pair,
which directly interacts with a-DsbA1. This reaction is inhibited by a non-catalytic disulfide present in a-DsbA1, conserved in
other a-proteobacterial DsbAs but not in c-proteobacterial DsbAs. This is the first characterization of the integral membrane
protein a-DsbB from Wolbachia and reveals that the non-catalytic cysteines of a-DsbA1 regulate the redox relay system in
cooperation with a-DsbB.
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Introduction
Wolbachia pipientis is one of the most common bacteria on earth,
infecting a wide range of invertebrates, including more than 65%
of insect species [1]. Wolbachia infects the gonads of its host,
altering its reproduction in a variety of unusual ways. In 1971, Yen
& Barr first discovered that the cross between healthy female
mosquitoes with Wolbachia-infected males did not produce viable
offspring, a phenotype called cytoplasmic incompatibility (CI) [2].
CI has been described in a wide range of insect species, and has
been particularly studied in Drosophila [3,4]. Although CI is the
most common form of reproductive manipulation induced by
Wolbachia in insects, Wolbachia can also cause feminization of
genetic males, parthenogenesis and male killing, depending on the
host species and the Wolbachia strain (for review see [4]). All of
these phenotypes favor an increased proportion of females in the
population, which supports Wolbachia’s maternal transmission [5].
The ability of some Wolbachia strains to inhibit several insect borne
diseases such as Dengue viruses, together with the capacity to
invade field populations as a consequence of CI induction, has
prompted the use ofWolbachia-infected Aedes aegypti mosquitoes as a
novel biocontrol tool against this disease [6–11].
The molecular mechanisms that underpin these Wolbachia-
induced phenotypes remain unclear, but it has been suggested that
the bacterium modifies host phenotypes through the action of
proteins secreted into the host cytoplasm [12,13]. A common
bacterial secretion pathway is the type IV secretion system (T4SS),
which enables bacteria to transfer DNA and proteins into its host
[14]. In several Wolbachia strains, two conserved operons of the
T4SS, virB3-B6 and virB8-D4, have been reported [15]. Although
the nature of the molecules secreted into the host environment
remains unknown, in close relatives of Wolbachia the T4SS is
known to secrete effector proteins such as Ankyrin-repeat-
containing proteins (ANK) [16–19]. Proteins containing ANK
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domains are often involved in protein:protein interactions, have
been shown to connect symbiont cell membranes to the
cytoskeleton, and are required for infection of the host cell [16–
19]. Wolbachia genomes are unusual among bacteria in that they
contain particularly high numbers of ANK genes [20–22]. The
high proportion of ANK genes, and the presence of a complete
T4SS, suggests that Wolbachia secretes effector proteins, such as
ANK into its host.
In bacteria, disulfide bond formation is critical for correct
folding and stability of secreted effector proteins. The introduction
of disulfide bonds is known as oxidative protein folding and
requires thiol-disulfide exchange reactions [23]. The disulfide
bond forming (Dsb) enzymes of the Escherichia coli K-12 strain are
known to fold many secreted protein substrates, including toxins
and surface proteins that contribute to bacterial virulence [24].
Therefore, it is likely that Wolbachia Dsb proteins also play essential
roles in maturation of effector proteins, before they are secreted
into the host.
In E. coli, the oxidative folding pathway requires two proteins,
EcDsbA and EcDsbB, that act together to introduce disulfide
bonds into newly synthesized proteins [25,26]. When EcDsbA
accomplishes this task, its active site cysteines become reduced and
must be re-oxidized to react with another substrate protein.
Oxidation of EcDsbA is catalyzed by an integral membrane
protein, EcDsbB [27,28]. EcDsbB contains four transmembrane
(TM) helices, two periplasmic loops (P1 and P2), and cytoplasmic
N and C-termini. The redox function of EcDsbB requires a pair of
cysteines in each of the P1 and P2 loops [27] and its oxidizing
power is sourced from a bound cofactor ubiquinone (UQ, redox
potential +110 mV [29]), though it is the P2 cysteine pair that
interacts directly with EcDsbA [30].
The genome of Wolbachia wMel strain encodes two DsbA-like
proteins, a-DsbA1 and a-DsbA2 [31], and a predicted integral
membrane protein a-DsbB with low sequence identity to EcDsbB.
Previous characterization of a-DsbA1 revealed striking differences
in the structure of a-DsbA1 compared to that of EcDsbA [31]. a-
DsbA1 possesses a second disulfide, that is likely to have a
regulatory role since it is not redox-active but it introduces local
strain into the enzyme structure [31]. The two cysteines forming
the second disulfide are highly conserved in alpha-proteobacterial
DsbAs but not in other DsbAs [31]. In addition, the a-DsbA1
structure lacks the characteristic hydrophobic surface features
surrounding the active site disulfide of EcDsbA [31]. Finally, a-
DsbA1 does not interact with EcDsbB, the redox partner of
EcDsbA [31].
Much attention is paid to the Wolbachia Dsb proteins because of
their potential role in folding Wolbachia effector proteins and the
interest in using Wolbachia as a biocontrol weapon. Here, we
investigated whether the predicted Wolbachia membrane protein a-
DsbB acts as a redox partner of either a-DsbA1 or a-DsbA2. We
found that a-DsbB and a-DsbA1 form a functional redox pair and
that their interaction mechanism resembles that of EcDs-
bA:EcDsbB, though the redox pairs are organism-specific: a-
DsbA1 does not interact with EcDsbB and a-DsbB does not
interact with EcDsbA. Curiously, we found no interaction between
a-DsbB and a-DsbA2, suggesting that a-DsbA2 has a distinct role
from that of other bacterial DsbAs.
Materials and Methods
Production of a-DsbA1, a-DsbA1CA and a-DsbA2
a-DsbA1 and its mutant form, a-DsbA1CA, were expressed and
purified as described previously [31,32]. Full-length a-DsbA2
(locus WD1312; GenBank #AE017196) was amplified from wMel
genomic DNA by PCR using the following primers: Forward 59
TAC TTC CAA TCC AAT GCG ATG AGC TTG CCG ATA
ATA 39 and Reverse 59 TTA TCC ACT TCC AAT G CT AGC
CTT GCT TGT GAC TTA A 39 to incorporate overhangs for
ligation independent cloning. Truncated a-DsbA2D50 was ampli-
fied using the primers: Forward 59 TAC TTC CAA TCC AAT
GCG GCT CGA GAT AAT GTA ACC 39 and Reverse 59 TTA
TCC ACT TCC AAT GCT AGC CTT GCT TGT GAC TTA
A 39. The full-length mature protein and a-DsbA2D50 were
cloned into the LIC vector pMCSG7 that incorporates a HIS6-tag,
a linker region containing 8 amino acids, and a TEV-cleavage site
at the N-terminus of the inserted gene. The construct was
transformed into the expression strain BL21(DE3)pLysS (Life
Technologies, USA) to enable over-expression of a-DsbA2 using
the autoinduction method [33]. Cells were collected using an
Avanti J-25I centrifuge (Beckman Coulter, Australia) at 12,000 x g
and 4uC for 10 min and frozen at -80uC. a-DsbA2 was expressed
and purified as described in [32] with minor variations to the lysis,
wash and elution buffers. These buffers contained 25 mM Tris-
HCl pH 7.5 (Sigma Aldrich, USA), 150 mM NaCl with 25 mM
imidazole for washing, and 250 mM imidazole for eluting the
protein.
Cloning, Expression and Purification of wt a-DsbB
Full-length a-DsbB was amplified from wMel (locus WD1099,
Accession No 966820) by PCR using specific primers: Forward 59
CAT ATG GTC AAT TAT CCC TGA AAG TAT AAA GCA
GAG TAT TGC TAG G 39 and Reverse 59 CTC GAG TTT
AGA TTT CTT TCT TTC ACA ATA CAC 39 including
restriction sites for NdeI and XhoI (underlined). The pET21a
vector into which the open reading frame of a-DsbB was inserted
was transformed into TOP10 competent cells (Life Technologies,
USA) for sequencing.
BL21(DE3)pLysS cells harboring the expression vector of a-
DsbB were cultivated in LB media containing ampicillin and
chloramphenicol and grown at 30uC until the OD600 reached 0.5.
Expression of a-DsbB was induced with IPTG (Thermo scientific,
USA)(250 mM final) and cells were incubated at 30uC for another
4 h. Cells were harvested in an Avanti J-26 Xpi centrifuge
(Beckmann Coulter, USA) at 7, 000 x g for 10 min. Bacterial
pellets were resuspended in buffer (10 mL of buffer per 1 g of cells)
containing 50 mM NaPO4 pH 8.0 (Biochemicals, Australia),
300 mM NaCl (Amresco, USA), 10% glycerol (Chem-Supply,
USA), 100 U DNAse (Roche, Australia), and 100 U protease
inhibitor cocktail (Roche, USA). Cell disruption was then carried
out using the bench top one-shot model (Constant Systems Ltd.,
USA) at 25 kPsi with two cycles of cell breakage. Unbroken cells
and debris were removed by centrifugation at 17, 000 x g for
20 min in an Avanti J-26 Xpi centrifuge (Beckmann Coulter,
USA). Membranes were harvested from the supernatant by
ultracentrifugation in an Optima L 100 XP (Beckmann, USA) at
100, 000 x g for 1 h at 4uC. The membrane pellet was solubilized
in buffer containing 50 mM NaPO4 pH 8.0, 300 mM NaCl, 10%
glycerol and 1% n-dodecyl-b-D-maltoside (b-DDM) (Affymetrix,
USA) for 1 h at 4uC. Solubilized membranes were ultracentri-
fuged at 100,000 x g for 20 min at 4uC to remove the
unsolubilized membrane fraction. The supernatant was then
added to TALONH resin (Clontech, Australia) (3 mL TALONH
per 50 mL lysate) and incubated for 1 h on a rotation wheel at
4uC. The resin was then washed with buffer as described above
and 20 mM imidazole and eluted from TALONH using buffer
including 50 mM NaPO4 pH 8.0, 300 mM NaCl, 0.03% b-DDM
and 250 mM imidazole. Eluted and concentrated protein was
injected onto a SuperdexTM 200 GL 10/300 column (GE
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Healthcare, USA) on an A¨KTA FPLC chromatographic system
(GE Healthcare, USA). To identify protein-containing fractions,
15 mL samples from peak fractions were applied to a 4–12% Bis-
Tris SDS PAGE (Life Technologies, USA). Protein-containing
fractions were concentrated in a 50, 000 Da cut-off AMICON
concentrator tube (Merck, USA) at 3, 000 x g at 4uC for
biochemical assays.
Preparation of a-DsbB variants [CCSS] and [SSCC]
To create a-DsbB [CCSS] and a-DsbB [SSCC] variants, we
used the following primers: Forward 59- CAT GAT GTT TTA
GGT AGT ACA GAG CAA GCA AGT AGT AAC G - 39 and
Reverse 59 - C GTT ACT ACT TGC TTG CTC TGT ACT
ACC TAA AAC ATC ATG 39, Forward 59 TAC TCT CCA
TCT TCG GAC AGA CCT CAT TAC - 39 and Reverse 59 GTA
ATG AGG TCT GTC CGA AGA TGG AGA GTA 39, and
Forward 59 - ATG CTG CCA TCC AAG TTA TCT ACA TAC
GAG CGA - 39 and Reverse 59 - TCG CTC GTA TGT AGA
TAA CTT GGA TGG CAG CAT - 39, respectively. PCR
products were cleaned using the QIAquick Gel Extraction Kit
(Qiagen, Netherlands) and transformed into TOP10 cells for
sequencing. The expression and purification steps were performed
as described for a-DsbB above.
Circular dichroism (CD) spectra of wt a-DsbB, a-DsbB
[CCSS] and a-DsbB [SSCC]
CD experiments were performed with wt a-DsbB, a-DsbB
[CCSS], and a-DsbB [SSCC]. Samples were measured in a UV-
cuvette (pathlength 1mm) in the far UV region using a J-810
spectropolarimeter (Jasco, USA). Samples had a protein concen-
tration of 5 mM and the buffer (500 mL) contained 50 mM NaPO4
pH 8.0, 100 mM NaCl and 0.1% b-DDM. Measurements were
performed in duplicate.
Reduction and oxidation of a-DsbA1 and a-DsbA2
a-DsbA1 and a-DsbA2 were reduced with 20 mM diothio-
threitol (DTT reduced) (A.G. Scientific, USA) or oxidized with
1.7 mM copper(II)-1,10-phenanthroline made from a 1:3 molar
ratio solution of CuCl2 (Sigma-Aldrich, USA) dissolved in water
and 1,10-phenanthroline (Sigma-Aldrich, USA) dissolved in
ethanol. The samples were incubated for 30 min on ice. To
remove DTT or copper(II)-1,10-phenanthroline, the sample was
applied to a PD10-Sephadex column (GE Healthcare, USA) and
eluted in degassed buffer containing 50 mM NaPO4 pH 8.0,
300 mM NaCl and 0.1% b-DDM. The Ellman assay was
performed to verify that the proteins were fully reduced. In this
assay, a colorimetric reaction occurs between Ellman’s reagent
5,5-dithiobis-2-nitrobenzic acid (DTNB) and free thiol groups.
The reagent is used to quantify free thiols in a sample. After
reaction of DTNB with a free thiol, TNB2- is released imparting a
yellow colour to the solution. The amount of TNB2- (and therefore
of free thiol) is quantified by measuring the absorbance of the
sample at 412 nm. For these experiments, a 1 ml reaction volume
was used with 2 mM of DTNB, and 36.2 mM of the sample
protein (a-DsbA1, a-DsbA1CA or a-DsbA2) in Ellman’s buffer
(80 mM NaPO4, 1 mM EDTA, 2% w/v SDS). Under these
conditions, an absorbance reading of 1.0 at 412 nm indicates the
presence of one free thiol in the protein sample. For example,
purified reduced a-DsbA2 gave an OD412 nm reading of
2.0560.03 (indicating the presence of two free thiols) whereas
purified oxidized a-DsbA2 gave an OD412 nm reading of
0.0560.01 (indicating no free thiols). OD412 nm measurements
were made using a CARY 50 Bio UV-spectrophotometer (Varian,
USA).
Ubiquinone reduction assay
The ability of a-DsbB to oxidize reduced a-DsbA1 and a-
DsbA2 in the presence of ubiquinone (UQ1, [34]) was assayed
spectrophotometrically using a CARY 50 UV-visible spectropho-
tometer (Varian, USA). The reduction of UQ1 can be measured
as a decrease in absorbance at 275 nm. The assay was performed
at 30uC in buffer (100 mL) containing 50 mM NaPO4 pH 8.0,
100 mM NaCl, and 0.1% b-DDM. a-DsbA1 (30 mM, 40 mL of a
75 mM stock solution) was mixed thoroughly with a-DsbB (50 nM,
5 mL of a 1 mM stock solution) and UQ1 (30 mM, 3 mL of a
1000 mM stock solution). The reduction rates of UQ1 were
calculated (using PRISM Version 6.0a [35]) from the decrease in
the linear absorbance curve. Measurements were performed in
triplicate.
Redox state analysis of a-DsbA1 and a-DsbA2 in the
presence of a-DsbB and variants
Reduced a-DsbA1 (30 mM, 40 mL of a 75 mM stock solution)
was mixed with a-DsbB (50 nM, 5 mL of a 1 mM stock solution)
and UQ1 (30 mM, 3 mL of a 1000 mM stock solution) in buffer
(100 mL) containing 50 mM NaPO4 pH 8.0, 100 mM NaCl, and
0.1% b-DDM and 5 mL samples were taken immediately after
mixing, and after 0.5 min, 2 min, 5 min, 30 min and 60 min.
These samples were mixed immediately with trichloroacetic acetic
acid (TCA, 10 mL of a 10% solution) (Sigma Aldrich, USA),
incubated on ice (10 min) and centrifuged (20, 000 x g, 10 min,
4uC). The supernatant was carefully discarded, pellets washed
(200 mL 100% cold acetone) and centrifuged (20,000 x g, 10 min).
The pellets were air-dried at room temperature for 20 min and
resuspended in buffer (10 mL) containing 50 mM Tris pH 7.0
(Amresco, USA), 1% SDS (Amresco, USA)) and 4 mM AMS
(Sigma, USA) to label free thiols. Samples were loaded onto a 12%
Bis-Tris gel. Three replicates were measured.
Redox potential of a-DsbB [CCSS] and [SSCC]
a-DsbB [CCSS] (2 mM, 3 mL of a 100 mM stock solution) and
a-DsbB [SSCC] (2 mM, 3 mL of a 100 mM stock solution) were
each incubated in fully degassed buffer (150 mL) containing
100 mM NaPO4 pH 7.0, 1 mM EDTA and 100 mM oxidized
DTT (Sigma-Aldrich, USA) and varying concentrations of
reduced DTT (2 mM – 5 mM) for 24 h at room temperature.
After incubation, the reactions were stopped with TCA (10%,
10 mL) and the precipitated protein pellets collected by centrifu-
gation at 16, 000 x g for 10 min at 4uC. The pellets were washed
with 100% cold acetone (200 mL) and dissolved in buffer (10 mL)
containing 50 mM Tris-HCl pH 7.0, 1% SDS and 2 mM AMS
(Molecular Probes, USA). Separation of reduced and oxidized
forms was detected on a 12% SDS Bis-Tris PAGE (Life
Technologies, USA). The stained gel was scanned and the band
intensity of reduced forms analyzed using ImageJ [36]. The
analyzed fractions of the reduced state were plotted against the
redox buffers. The equilibrium constant Keq and the redox
potential E0’ were calculated as described previously [31].
Experimental data were measured in duplicate.
Peptide oxidation by a-DsbA1
EcDsbB was expressed and purified as described previously
[37]. The peptide substrate CQQGFDGTQNSCK, with a
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)
group amide-coupled to the N-terminus, and a methylcoumarin
Wolbachia pipientis DsbA:DsbB Interaction
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amide-coupled to the e-amino group of the C-terminal lysine, was
purchased from AnaSpec, USA. Reconstitution of the peptide
substrate solution has been described previously [38].
Assays were run on a Synergy H1 Multimode plate reader
(BioTek, USA) with excitation at l=340 nm and emission at
615 nm. For time-resolved fluorescence, a 100 msec delay before
reading and 200 msec reading time was employed. The assay was
performed in a white 384-well plate (Perkin Elmer, USA). A
solution (25 mL) containing 500 nM a-DsbA1 in 50 mM MES,
50 mM NaCl, 2 mM EDTA, pH 5.5 was added to the wells. The
assay was initiated by the addition of peptide (16 mM in 25 mL of
50 mM MES, 50 mM NaCl, 2 mM EDTA, pH 5.5) to each well.
The final reaction per well contained a-DsbA1 (500 nM, 5 mL of a
5 mM stock solution), a-DsbB (1.6 mM, 5 mL of a 16 mM stock)
and peptide substrate. Three replicates were measured.
Results
Wolbachia a-DsbB is predicted to have the same
topology as E. coli DsbB
Wolbachia wMel a-DsbB shares just 17% sequence identity with
EcDsbB (Figure 1). However, a sequence-based structure
prediction of a-DsbB suggests that it has the same membrane
topology with four TM helices (Topcons [39] and TMHMMfix
[40]). Similar to EcDsbB, a-DsbB has two cysteines located in
each of its periplasmic loops: Cys50 and Cys53 in P1 and Cys111
and Cys137 in P2 (Figure 1). Moreover, Arg58 of a-DsbB is
located at a position equivalent to that of the ubiquinone–
interacting residue Arg48 of EcDsbB [41] (Figure 1). a-DsbB is
predicted by Psipred [42] to contain two short a-helices a1 and a2,
where a1 is located at the N-terminus of the protein and a2 in the
P2 loop (Figure 1). These two helices are also present in the same
regions of EcDsbB but both are shorter than the helices predicted
in a-DsbB (Figure 1). Indeed, the a-DsbB N-terminal region is
longer overall than that of EcDsbB (Figure 1).
Despite the low sequence identity, a-DsbB and EcDsbB may
have a similar function because the predicted membrane topology
and the position of critical residues of a-DsbB (e.g. the four
periplasmic loop cysteines and Arg 58) appear to be conserved.
CD confirms that a-DsbB is helical
a-DsbB was produced using recombinant expression methods in
E. coli and the protein was extracted from membranes by detergent
solubilization. The protein-detergent micelles were purified using
affinity and size exclusion chromatography, to give a final yield of
,3 mg of purified a-DsbB from 1L of culture. We also
constructed two variants a-DsbB [SSCC] and a-DsbB [CCSS],
in which the two cysteines in each of the periplasmic loops were
replaced with serines. CD measurement of wild type a-DsbB and
both variants revealed far UV CD spectra (Figure 2) consistent
with a predominantly a-helical protein (84% helix [43]). This
finding supports the notion that the overall fold of a-DsbB is
similar to that of the helical EcDsbB protein. Furthermore, there
was no significant difference between the CD spectra for the wild
type and variant forms of a-DsbB, indicating that the overall fold
was unaffected by the Cys to Ser mutations (Figure 2).
Figure 1. a-DsbB is helical with a predicted topology similar to that of EcDsbB. Sequence-based secondary structure prediction for a-DsbB
was derived using Topcons [39], TMHMMfix [40] and PsiPred [42] and the EcDsbB secondary structure was derived from the crystal structure [49]. a-
DsbB and EcDsbB both have four conserved cysteine residues (highlighted in yellow), two in each periplasmic loop. The four transmembrane regions
of each protein, TM1–TM4, are boxed. Another two helices are present in EcDsbB (a1 at the N-terminus and a2 in loop P2, grey boxes) [56], and these
were also predicted in a-DsbB, though the N-terminal helix is much longer than in EcDsbB. Arg48 of EcDsbB and Arg58 of a-DsbB are highlighted in
cyan; this residue binds the quinone cofactor in EcDsbB. The sequence alignment of the two proteins was performed using ClustalW [57] with manual
adjustments to align loop cysteines and predicted TM helices.
doi:10.1371/journal.pone.0081440.g001
Figure 2. a-DsbB is helical. CD spectra in the far UV region of
oxidized wt a-DsbB (dotted line) and [CCSS] (dashed line) and [SSCC]
(solid line) variants. The spectra shown are the mean of three replicates.
doi:10.1371/journal.pone.0081440.g002
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a-DsbB oxidizes a-DsbA1 but not a-DsbA2
As the role of EcDsbB is to oxidize EcDsbA, the next question
to address was whether a-DsbB formed a functional redox pair
with either or both a-DsbA1 and a-DsbA2. a-DsbA1 and a-
DsbA2 have 21% sequence identity to each other, and 11% and
19% with EcDsbA, respectively (PDB codes: 3F4R, 1DSB)
[31,44]. The structure of a-DsbA1 shows that it has a DsbA fold
comprising a thioredoxin domain and an inserted helical domain.
The structure of a-DsbA2 is not known though it has a longer N-
terminal region than a-DsbA1 and other DsbAs. This region of a-
DsbA2 is predicted (PredictProtein [45]) to be helical. A gel-shift
assay was used to assess the redox state of both a-DsbA enzymes
after incubation with a-DsbB. The a-DsbA enzymes were fully
reduced before they were incubated with a-DsbB, and samples
were taken from the reaction mixture at a number of time points
to investigate the extent of oxidation of the a-DsbA proteins in the
presence of a-DsbB and ubiquinone. Detection of the oxidation
state was done by labeling free thiols. Thus, thiols of reduced
cysteines in a-DsbA1 or a-DsbA2 were labeled with 4-acetamido-
49-maleimidylstilbene-2,29-disulfonic acid (AMS), which led to an
increase in mass (500 Da) for each free cysteine and hence a slower
band migration on a 12% Bis-Tris PAGE gel according to the
number of free cysteines.
This assay showed that reduced a-DsbA1 (determined using the
Ellman assay) was converted to oxidized a-DsbA1 relatively
quickly in the presence of a-DsbB and exogenous ubiquinone-1
(UQ1) (Figure 3A). Oxidized a-DsbA1 was detectable within 30 s
and oxidation was complete within 10 min. The non-catalytic
disulfide of a-DsbA1 has been proposed to play a regulatory role
[31], so an a-DsbA1 variant was used in which the cysteines of the
non-catalytic disulfide were replaced with alanine (a-DsbA1CA),
and this variant was evaluated in the same assay. Interestingly, the
time course of oxidation of the variant indicated that it was
oxidized more rapidly than wt a-DsbA1. After 30 sec, oxidation
appeared to occur 3 times faster for the variant than the wt
enzyme and at 2 min and 5 min, respectively, the amount of
oxidized variant versus oxidized wt enzyme was 2-fold and 1.3 fold
greater. (Figure 3A, B). In the absence of exogenous UQ1, a-
DsbA1 remained reduced (determined by Ellman assay) over
60 min (Figure 3C). The same assay showed that a-DsbB was
unable to oxidize a-DsbA2, which remained fully reduced
(determined by Ellman assay) throughout the 60 min, even in
the presence of exogenous UQ1 (Figure 3D). Taken together, the
results demonstrated that a-DsbB oxidized a-DsbA1 but not a-
DsbA2 and that this reaction required the presence of an oxidizing
quinone cofactor.
UQ is reduced during a-DsbB-catalysed oxidation of a-
DsbA1
The observation that a-DsbA1 was oxidized by a-DsbB in the
gel-shift assay, and that this oxidation required stoichiometric
amounts of exogenous UQ1 suggested that a-DsbB catalysis
involved the reduction of UQ and subsequent exchange with
oxidized UQ. This is similar to the EcDsbB system [29]. We
investigated this possibility by monitoring the decrease of
absorbance at 275 nm during the catalytic oxidation of a-DsbA1
by a-DsbB (Figure 3E).
When a-DsbB was mixed with a-DsbA2, the exogenous
UQ1 was not reduced, confirming the results of the gel shift
assay that the two proteins do not form a functional redox
pair (Figure 3E). However, when a-DsbA1 was mixed with a-
DsbB and UQ1, a significant decrease of absorbance at 275 nm
was observed, indicating that UQ1 reduction was coupled with
a-DsbB-mediated oxidation of a-DsbA1 (Figure 3E).
While the initial rate of UQ1 reduction was 0.23616
0.0014 min21 for wt a-DsbA1, the rate increased to
0.462660.0016 min21 for the variant a-DsbA1CA (Figure 3E).
This observation and results from the previous assay (Figure 3A,
B) suggested that the second disulfide of a-DsbA1 played a
regulatory role by inhibiting a-DsbA1 oxidation by a-DsbB.
Both cysteine pairs in the a-DsbB periplasmic loops are
required for a-DsbA1 oxidation
We next investigated the importance of the a-DsbB periplasmic
loop cysteine pairs for a-DsbA1 oxidation. In EcDsbB, all four
periplasmic loop cysteines are required for oxidation of EcDsbA
Figure 3. Redox interplay of a-DsbB with a-DsbA1, but not with
a-DsbA2. (A) a-DsbA1 was oxidized in the presence of a-DsbB and
UQ1; (B) a-DsbA1CA was oxidized in the presence of a-DsbB and UQ1;
(C) a-DsbA1 was not oxidized in the presence of a-DsbB and absence of
UQ1; lanes marked ‘‘red’’ and ‘‘ox’’ indicate samples of reduced or
oxidized a-DsbA1, confirmed by use of Ellman’s reagent (D) a-DsbA2
was not oxidized in the presence of a-DsbB and UQ1; lanes marked
‘‘red’’ and ‘‘ox’’ indicate samples of reduced or oxidized a-DsbA2,
confirmed by use of Ellman’s reagent (E) Ubiquinone reduction. UQ1
was not reduced when a-DsbB/UQ1 was mixed with a-DsbA2 but was
reduced when a-DsbB/UQ1 was mixed with a-DsbA1 or with a-
DsbA1CA. Samples of a-DsbA1, a-DsbA1CA and a-DsbA2 were in the
fully reduced state (confirmed by use of Ellman’s reagent) prior to
mixing with a-DsbB/UQ1. The data shown are representative of three
replicates.
doi:10.1371/journal.pone.0081440.g003
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[46], and we expected that the same would be true for a-DsbB. To
test this, the oxidative activity of two variants a-DsbB [CCSS] and
a-DsbB [SSCC] was investigated using a gel-shift approach.
The results showed that a-DsbA1 remained fully reduced after
60 min when either of the a-DsbB variants was added in the
presence of UQ1 (Figure 4A and B), indicating that the cysteine
pairs in both periplasmic loops were essential for a-DsbA1
oxidation. In the reverse reaction, we tested whether oxidized a-
DsbA1 was able to oxidize the thiols of reduced a-DsbB [CCSS]
or reduced a-DsbB [SSCC]. After 45 min, there was no evidence
that a-DsbA1 underwent thiol-disulfide exchange with reduced a-
DsbB [CCSS] (Figure 4C), but more than 50% of a-DsbB
[SSCC] was oxidized within 15 min (Figure 4D), suggesting that
the cysteines in the second periplasmic loop interacted with a-
DsbA1.
The oxidation of reduced a-DsbB [CCSS] and [SSCC] by
exogenously added UQ1 was also assessed. UQ1 re-oxidized a-
DsbB [CCSS] rapidly, within 2 min (Figure 5A). However, UQ1
could not oxidize the a-DsbB [SSCC] variant, which remained
reduced over the 60 min incubation (Figure 5B). These results
suggested that the cysteines of the first periplasmic loop interact
with UQ1 and that the cysteines of the second periplasmic loop
interact with a-DsbA1, as part of a redox relay.
Redox potentials of a-DsbB cysteine pairs are more
reducing than that of a-DsbA1
EcDsbA has a standard redox potential of2122 mV [47], which
is highly oxidizing for thioredoxin superfamily proteins. However,
the redox potentials of DsbA enzymes varies considerably:
a-DsbA1 is one of the most reducing with a redox potential of
2163 mV [31]. We determined the redox potentials of the two
essential cysteine pairs in a-DsbB and compared them to those of
EcDsbB.
We used the a-DsbB variants [CCSS] and [SSCC] to determine
the redox potential of the two cysteine pairs by gel-shift analysis of
their reduced and oxidized states at various ratios of oxidized
DTT (DTTox) versus reduced DTT (DTTred) (Figure 6A). We
found that the redox potentials of the variants [CCSS] and
[SSCC] were more reducing than those measured for the
counterparts of EcDsbB [46]. Thus, from the experimentally
determined equilibrium constants, the redox potentials of aDsbB
were calculated to be -251 mV and2275 mV for the cysteine pair
in the P1 loop and the P2 loop, respectively (Figure 6B). In
comparison, EcDsbB has redox potential values of 2207 mV for
the P1 and 2224 mV for the P2 loop cysteine pairs [46]. These
results show that in both E. coli and Wolbachia, the highly oxidizing
UQ cofactor (redox potential, +110 mV) is critical to enable DsbB
to oxidize DsbA efficiently.
a-DsbB and a-DsbA1 form a functional redox pair that
oxidizes peptide cysteines
Finally, the redox partnership of a-DsbA1 and a-DsbB was
probed by assessing their ability to catalyze cysteine oxidation in a
peptide substrate. In this assay, a synthetic peptide was used
containing two cysteines and tetraazacyclododecane-1,4,7,10-
tetraacetic acid (DOTA) and Europium (Eu) doped methylcou-
marin groups at the N- and C-termini, respectively. When a
disulfide is formed between the two cysteines of the peptide,
DOTA and Eu are brought into close proximity, resulting in
fluorescence emission. An increase in fluorescence is indicative of
disulfide formation in the peptide.
The rate of peptide oxidation by a-DsbA1 was assessed in the
presence of three different oxidation sources: (i) a-DsbB (crude
membrane containing endogenous UQ); (ii) oxidized glutathione
buffer; or, (iii) EcDsbB (crude membrane containing endogenous
UQ). For the wild type a-DsbA1/a-DsbB membranes, the peptide
was oxidized at an initial rate of 4.7761023 (62.961026) min21
(Figure 7). In the presence of wt a-DsbA1/GSSG, peptide
oxidation occurred at a similar initial rate of 4.8261023
(62.461025) min21. However, with a-DsbA1/EcDsbB mem-
branes no peptide oxidation was observed, indicating that a-
DsbA1 did not interact with EcDsbB. Likewise, EcDsbA was
incapable of catalyzing peptide oxidation in the presence of a-
DsbB membranes.
The activity of the variant a-DsbA1CA was also investigated in
this assay, in the presence of wt a-DsbB membranes. Under the
same conditions, the peptide was oxidized more rapidly by a-
DsbA1CA than by wt a-DsbA1 (6.2161023 (63.461026) min21).
Figure 4. Redox states of wt a-DsbA1 in reaction with a-DsbB
[CCSS] and [SSCC]. (A) a-DsbA1 was not oxidized in the presence of
a-DsbB [CCSS] and UQ1; the first lane shows a reference sample
comprising a mixture of reduced and oxidized wt a-DsbA1. (B) a-DsbA1
was not oxidized in the presence of a-DsbB [SSCC] and UQ1; the first
lane shows a reference sample comprising a mixture of reduced and
oxidized wt a-DsbA1. (C) Oxidized a-DsbA1 did not oxidize a-DsbB
[CCSS] and hence remained oxidized in the presence of a-DsbB [CCSS];
(D) Oxidized a-DsbA1 oxidized more than 50% of reduced a-DsbB
[SSCC] through thiol-disulfide exchange with reduced a-DsbB [SSCC],
yielding significant amount of reduced a-DsbA1. Data shown are
representative of two replicates.
doi:10.1371/journal.pone.0081440.g004
Figure 5. UQ1 interacts with the first periplasmic loop of a-
DsbB. (A) UQ1 was able to fully oxidize a-DsbB [CCSS] within 2 min; (B)
UQ1 did not oxidize a-DsbB [SSCC]; lanes marked ‘‘red’’ and ‘‘ox’’ lanes
indicate samples of reduced and oxidized a-DsbB [SSCC], respectively.
Data shown are representative of two replicates.
doi:10.1371/journal.pone.0081440.g005
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Discussion
The introduction of disulfide bonds into bacterial effector
proteins is essential for their stability and function. Wolbachia
encodes two putative periplasmic DsbA-like proteins, a-DsbA1
and a-DsbA2, and a putative integral membrane protein, a-DsbB.
Sequence-based structure prediction suggested that a-DsbB has
the same overall membrane topology as EcDsbB, and we proposed
that the cysteine pairs in the two periplasmic loops (P1 and P2) of
a-DsbB would play a similar role to those of EcDsbB in the
oxidation of EcDsbA. Indeed, we showed that a-DsbB was a
helical membrane protein and that a-DsbB and a-DsbA1 formed
a functional redox pair with a highly specific electron flow
pathway driven by UQ. The W. pipientis wMel genome contains a
gene encoding a UQ biosynthesis protein Coq7 (accession code:
IP011566), suggesting the biosynthesis of UQ in Wolbachia is
similar to that in E. coli [48].
The a-DsbB variants [CCSS] and [SSCC] were used to
measure the redox potentials of the cysteine pairs of P1 and P2
which are both relatively reducing, at 2252 mV and 2273 mV,
respectively. This observation raises the question of how wt a-
DsbB can oxidize a-DsbA1 which has a more oxidizing redox
potential (2163 mV for wt a-DsbA1 and 2161 mV for a-
DsbA1CA [31]) than the cysteine pairs of a-DsbB. A similar
observation was made for the EcDsbB:EcDsbA system. In
EcDsbB, the UQ cofactor is highly oxidizing (redox potential
+110 mV), is essential for the oxidation relay and plays a key role
in overcoming the unfavourable redox potential difference
between EcDsbB and EcDsbA [27]. Moreover, previous studies
suggested that three structural elements would be involved in
efficient DsbB catalysis of DsbA oxidation: i) DsbA-induced
separation of Cys104 from Cys130 in DsbB [25,49,50]; (ii) a
membrane-parallel a-helix of EcDsbB that is peripherally bound
to the membrane and restricts movement of Cys130 [51]; and, (iii)
transient formation of an interloop disulfide bond Cys41 and
Cys104 in EcDsbB [52,53]. All three mechanisms likely contribute
to preventing the backward attack of liberated EcDsbB Cys130 on
the intermolecular disulfide bond formed between EcDsbB
Cys104 and EcDsbA Cys30. Since a-DsbA1 lacks the hydrophobic
peptide-binding groove of EcDsbA [31], a similar a-DsbA1-
induced conformational change of a-DsbB may not be relevant in
this system. However, a-DsbB is predicted to have an a-helix in
the P2 loop which could play a similar role to the membrane-
parallel helix of EcDsbB, and the essential cysteines of a-DsbB are
located at positions equivalent to those of EcDsbB (Figure 1). The
oxidative systems of E. coli and Wolbachia thus appear to operate in
a similar manner to catalyze protein disulfide formation.
On the other hand, the data presented here provides strong
evidence that the E. coli and Wolbachia DSB systems are organism
specific. That is, a-DsbA1 oxidized a synthetic peptide when its
Figure 6. Redox potentials of the cysteine pairs in the P1 and
P2 loops of a-DsbB. (A) Redox equilibria of a-DsbB [CCSS] and a-
DsbB [SSCC]. After equilibration in redox buffers of varying [DTTred]/
[DTTox] ratios for 24 h, samples were treated with 10% TCA and free
cysteines were labeled with AMS. Reduced and oxidized proteins were
separated by 12% SDS-PAGE under non-reducing conditions. (B) Redox
potentials of a-DsbB [CCSS] and a-DsbB [SSCC]. The fractions of a-DsbB
[CCSS] or a-DsbB [SSCC] in the reduced state were calculated using
ImageJ [36] and equilibrium constants were plotted against the fraction
of the reduced state in PRISMH using the one phase decay option. The
data presented are the standard mean and error from duplicate
measurements.
doi:10.1371/journal.pone.0081440.g006
Figure 7. Peptide dithiol oxidation catalyzed by a-DsbA1.
Fluorescence curves showing oxidation of a thiol-containing peptide
catalyzed by: a-DsbB membranes with a-DsbA1 and a-DsbA1CA;
EcDsbB membranes with a-DsbA1; a-DsbB membranes with EcDsbA;
or glutathione with a-DsbA1 and a-DsbA1CA. Data represent the
standard mean and error of three replicates.
doi:10.1371/journal.pone.0081440.g007
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organism specific redox partner a-DsbB/UQ was present but not
when EcDsbB/UQ replaced its partner. Conversely, EcDsbA
oxidized a cysteine-containing peptide in the presence of EcDsbB/
UQ, but not in the presence of a-DsbB/UQ [54]. This specificity
could be attributed to protein surface differences between EcDsbA
and a-DsbA1 and sequence differences between the P2 loops of
EcDsbB and a-DsbB. The active site disulfide of EcDsbA is
adjacent to a hydrophobic groove that interacts with EcDsbB
[24,31,44] by accommodating the residues PSPFATCDF of the P2
loop (Figure 1). There is no equivalent groove in a-DsbA1, and
the region around the a-DsbA1 active site contains basic residues
[31]. In parallel, the residues of the a-DsbB P2 loop
(FHDVLGCTE) are less hydrophobic and more acidic than those
of EcDsbB (Figure 1).
Another remarkable difference between the two systems is the
presence of two cysteines in the helical domain of a-DsbA1 in
addition to the redox active site cysteines in the thioredoxin
domain. We had noted this second disulfide previously [31], and
found that: (i) the two cysteines are highly conserved in a-DsbAs;
(ii) the disulfide is not redox-active but introduces local stress into
the a-DsbA1 structure; and, (iii) the disulfide does not affect the
intrinsic redox properties of a-DsbA1 [31]. The high degree of
conservation and the unusual conformation of the second disulfide
suggested that it might play a regulatory role. Indeed, oxidation of
the two cysteines in the helical domain almost halved the reaction
rate of a-DsbA1 with a-DsbB, and the rate of model peptide
oxidation by a-DsbA1 was also reduced. This discovery implies
that the Wolbachia a-DsbA1:a-DsbB oxidative system is subject to
feedback regulation through redox-sensing by these cysteines. In
this respect, the Wolbachia Dsb system may share regulatory
features of the eukaryotic endoplasmic reticulum (ER) Ero1p:PDI
oxidative system [55] in which ER hyperoxidation is prevented by
attenuation of Ero1p activity through noncatalytic cysteine pairs.
It will be interesting to determine the redox potential of this
putative regulatory disulfide and investigate which molecules
regulate its formation/cleavage under physiological condition.
In summary, Wolbachia a-DsbB and a-DsbA1 form a functional
redox pair analogous, but not equivalent, to that of E. coli. By
analogy to the E. coli system, a-DsbA1 and a-DsbB constitute an
oxidative pathway required for the oxidative folding of cysteine-
containing effector proteins in the Wolbachia periplasm. The two
enzymes in the E. coli and Wolbachia systems are not interchange-
able. EcDsbA uses a hydrophobic groove absent in a-DsbA1 to
interact with its EcDsbB partner; and Wolbachia a-DsbA1 has
regulatory non-catalytic cysteines absent in EcDsbA. The role of
the second Wolbachia DsbA enzyme, a-DsbA2, in oxidative folding
requires further investigation, but clearly it does not play the same
role as a-DsbA1 or EcDsbA because it does not interact with a-
DsbB.
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